2023. miR-145-5p and miR-203a-5p overcome imatinib resistance in myelogenous leukemic cells through metabolic reprogramming. Indian Journal of Biochemistry and Biophysics (IJBB). 60, 3 (Jun. 2023), 167–176. DOI:https://doi.org/10.56042/ijbb.v60i3.66526.